Objective: Peripheral arterial disease (PAD) is a significant age-related medical condition with limited pharmacologic options. Severe PAD, termed critical limb ischemia, can lead to amputation. Skeletal muscle is the end organ most affected by PAD, leading to ischemic myopathy and debility of the patient. Currently, there are not any therapeutics to treat ischemic myopathy, and proposed biologic agents have not been optimized owing to a lack of preclinical models of PAD.
amputation. 3, 4 Patients with PAD have abnormal skeletal muscle morphology from persistent ischemia, and this leads to limb dysfunction. 5 In more severe manifestations, PAD can progress to critical limb ischemia (CLI); here, there is inadequate perfusion to meet resting tissue demands. CLI is a devastating disease affecting an estimated 500,000 to 1 million patients annually, and up to 10% of PAD patients older than 50 years will develop CLI within 5 years of diagnosis. 6 There are limited therapeutic options for PAD patients beyond those prescribed for cardiovascular disease, 7 and none target ischemic myopathy directly. 8 Furthermore, whereas surgical revascularization restores perfusion and can be life and limb saving, 9 it is typically reserved for patients who fail to respond to medical therapy or who have progressed to CLI. In these patients, surgical revascularization may not always be enough to prevent amputation, 10 and the amputation rate can still approach 30% at 1 year. 11 Because 33% to 50% of CLI patients do not have suitable anatomy or available conduit for revascularization, 12 major amputation remains the only treatment option for many patients. 13 Given the increased incidence and prevalence of PAD/ CLI worldwide, this disease is likely to impose an even greater burden on the health of patients in the years to come. 14, 15 Thus, there is a critical need to develop novel therapies to limit ischemic myopathy and to promote limb salvage. Biologic therapies are a promising approach for PAD patients. Here, cells, genes, or angiogens could improve wound healing, restore perfusion to ischemic tissue, and improve ischemic myopathy and function. However, the optimal delivery methods and dosing strategies are not known and cannot be tested in these trials. 16 Thus, the lack of a translational model for new pharmaceutical and biologic agents may play a role in the failure of some clinical trials. 17, 18 A large animal model of ischemic myopathy from PAD may be useful in preclinical testing of these promising therapeutics. The choice of a large animal for this study is in accord with the Food and Drug Administration guidance for investigators regarding the development of cellular therapies for cardiovascular disease. Here, the Food and Drug Administration accepts the limitations of small animal models and states that "large animal models.can provide information on the safety and activity of cellular products and delivery systems, leading to the selection of a potentially safe starting dose for a Phase 1 clinical trial." 19 To date, published large animal models of PAD have been limited by rapid collateralization that is not seen in PAD patients clinically and diminishes the time frame of ischemia to less relevant durations. In addition, many models contaminate the tissue with iatrogenic local tissue injury. 20 Obviously, the prevention of rapid collateralization will provide for a more durable ischemic state, and a sustained plateau period of limb ischemia is desirable for testing new agents. Importantly, the degree of ischemia must not be disabling or accompanied by severe morbidity so that test therapeutic agents can be adequately tested. Endovascular techniques can also limit local tissue trauma. Thus, the objective of this study was to develop a large animal model of ischemic myopathy from PAD for use in testing novel therapeutics. This model uses endovascular occlusion of the external iliac artery (EIA) in two breeds of swine (one with and one without metabolic syndrome), and this work describes the return of ambulatory function and quantifies arterial perfusion and ischemic myopathy during 5 to 6 weeks after induction of hindlimb ischemia.
METHODS

Animals and animal care
Sexually mature female Yorkshire swine (N ¼ 8), 6 to 8 months of age (average weight, 52.9 kg [63.2 kg]), were obtained from a local vendor. Similarly aged Ossabaw swine (N ¼ 8) were obtained from Indiana University. The Ossabaw swine were fed a high-fat diet, which leads to a metabolic syndrome phenotype. 21, 22 All animals were handled in compliance with the Guide for the Care and Use of Laboratory Animals, published by the National Institutes of Health, and according to the guidelines of the Emory University Institutional Animal Care and Use Committee. Swine diet and feeding. Yorkshire swine were acclimated for 1 week before experimentation and fed standard chow diet. For 6 months before experimentation, Ossabaw swine were fed 1 kg/d atherogenic obese diet (KT324; Test Diet, St. Louis, Mo) composed of 2% cholesterol, 17% coconut oil, 2.5% corn oil, and 0.7% sodium cholate as published. 21, 22 Perioperative care. A preoperative analgesic (buprenorphine, 0.15 mg for each pig) was given along with a perioperative antibiotic (cefazolin, 1000 mg). Perioperative heparin was given to keep activated clotting time >300 seconds during the procedure. Postoperatively, buprenorphine (0.15-0.3 mg) was given immediately after the procedure and intermittently at the discretion of the veterinary team as warranted for the animal's discomfort.
In vivo model of CLI in Yorkshire swine
Swine were anesthetized and intubated under standard conditions and then maintained on isoflurane gas and ventilator through the entirety of each operation. 20 Preoperative hindlimb indices (HLIs) of blood pressure and duplex ultrasound of the common femoral arteries were recorded on both hindlimbs.
Arterial access. The first two Yorkshire pigs underwent percutaneous access to the ipsilateral right common femoral artery, but we converted to an open carotid artery exposure to avoid manipulation of tissue in the access limb of the remaining animals.
Induction of hindlimb ischemia. The right common carotid artery was accessed over a starter wire with a 9F sheath, and the sheath was secured to the carotid artery with 2-0 silk suture ligatures. A 6F vertebral catheter was then advanced over a 0.035-inch Bentson wire into the descending aorta with the use of fluoroscopy to navigate the aortic arch. The catheter was advanced over a wire to the site of the aortic trifurcation. Approximately 6 mL of 50% strength Isovue contrast agent was used for each arteriogram, totaling 10 arteriograms for the initial procedure. We first imaged the aortic trifurcation (Fig 1) . Bilateral EIAs and the common iliac artery were identified. The left EIA was then selected for imaging the common femoral/superficial femoral artery in two planes and then the below-knee runoff separately. The right side was treated in the same manner, but the right EIA was then reimaged to demonstrate its ostia, the lateral circumflex branch, and the medial profunda branch for proper placement of the stent (Fig 1) . The Bentson wire was advanced into the superficial femoral artery, and the catheter was removed. A GORE Viabahn covered stent (7 or 8 mm Â 10 cm; W. L. Gore & Associates, Flagstaff, Ariz) was then placed in the right EIA/common femoral artery, functionally excluding the orifices of the circumflex iliac and profunda artery. Proper placement with exclusion of the lateral circumflex and profunda arteries was subsequently confirmed by selective arteriography. The vertebral catheter was then reintroduced to the EIA over the wire to position it midway into the stent. A 10-mm Amplatzer vascular plug (St. Jude Medical, St. Paul, Minn) was then delivered through the vertebral catheter and deployed in its "double bubble" configuration in the proximal stent. Completion aortograms were then obtained 2 minutes after deployment to confirm occlusion and to capture outflow bilaterally. At the conclusion of the procedure, the right common carotid artery was ligated with 2-0 silk sutures, and the wound was closed in two layers. Finally, completion HLI and ultrasound measurements were performed as before. The animal was then awakened and recovered by our veterinarian team before departure to its cage. The left hindlimb's arterial supply was not manipulated and served as the control limb for comparison.
In vivo CLI model in Ossabaw swine. Obese female swine (N ¼ 8) were treated similarly, but the EIA was stented with a 6-mm Â 10-cm Viabahn stent because of the smaller size of the arteries, and an 8-mm Amplatzer plug was used. Of note, these animals were used as placebo control animals from a recent publication. 21 These animals were used to demonstrate how our model can be used in swine with features more representative of clinical diseases relevant to PAD (here metabolic syndrome). Unpublished data (ischemic myopathy and arteriogenesis) from that study are included in this study as comparison with Yorkshire animals to demonstrate the reliability of this model in two distinct strains of swine. HLI measurement and calculation. HLIs were measured using continuous-wave Doppler ultrasound of the tarsal arteries and a pediatric blood pressure cuff at the ankle joint. After successful identification of the arterial signal, the cuff pressure was then rapidly increased w30 mm Hg above occlusion of the signal. The cuff was then slowly released until the return of the arterial signal was identified. The ischemic limb (right) occlusion pressure was then compared with the normal limb (left) as the HLI. Animals were anesthetized for immediate postprocedure and terminal measurements; they were sedated for the interim measurements.
Duplex ultrasound of common femoral and superficial femoral arteries. Duplex ultrasound (Vivid i, i12L-RS Probe; GE Healthcare, Erlangen, Germany) was performed and recorded for each artery. Short-and longaxis views of the superficial femoral artery on both legs were acquired with multiple Doppler planes looking for flow distal to the implantation site. Pulsed wave Doppler was acquired in both short and long axis to quantify the peak systolic and end-diastolic velocity of blood flow. Animals were anesthetized for immediate postprocedure and terminal measurements; they were sedated for the interim measurements.
Serial examinations of animals after induction of hindlimb ischemia. All Yorkshire swine underwent weekly duplex ultrasound measurements of the common femoral and superficial femoral arteries and HLI. Videos of the gait of the Yorkshire swine were captured weekly in the animal vivarium to capture gait abnormalities using a Canon EOS Rebel T3 camera.
Terminal arteriography. At 5 weeks after occlusion, all swine underwent left common carotid artery access and repeated arteriography as described before. The Euthanasia and tissue collection. After completion of all the studies, the Yorkshire swine were euthanized under deep anesthesia with a lethal dose of potassium chloride. The animals were then brought to the necroscopy room for tissue collection.
Manual and automatic quantification of ischemic myopathy
Gastrocnemius muscle samples were collected from the animals during necroscopy. Sections from the gastrocnemius of the swine were obtained and stained with hematoxylin-eosin. Manual slide review was performed on the Ossabaw swine gastrocnemius and plantaris muscles in a blinded fashion as published. 5, 23 Automated quantification of Yorkshire swine was developed using a custom MATLAB (MathWorks, Natick, Mass) subroutine to quantify muscle morphologic features. Micrographs were acquired on a standard inverted microscope (IX51 inverted microscope; Olympus America, Inc, Melville, NY) using a phase-contrast objective (X10 UPLFLN series, numerical aperture: 0.3; Olympus America, Inc). Image processing techniques (eg, filtering, size exclusion, edge detection) were applied to each image to extract myofiber tissue and to quantify myofiber areas. An image of a standard stage micrometer (0.01-mm markings) was acquired with identical imaging equipment and settings to accurately determine image resolution.
Arteriography image analysis
Time-of-flight and WSS analyses. Arterial flow was measured directly from the initiation of contrast material bolus in the distal aorta until time of the contrast agent's entering the common femoral artery. Measurements compared right (occluded EIA) with left (normal EIA) at completion arteriography. WSS values were calculated before CLI and at 35 days after CLI from the acquired imaging and hemodynamic data. Common femoral artery diameters were extracted from the angiographic data at peak systole. Pulsatile Doppler-derived velocity values were digitized from the recorded data. Under the assumptions for Poiseuille flow, which results in a reduced form of the Navier-Stokes equations that govern fluid dynamics, WSS values were calculated.
Arteriogenesis in the internal iliac artery (IIA). The porcine anatomy is favorable to this model as the ipsilateral IIA is derived from the common iliac artery. IIA diameters were measured before occlusion and at 5 weeks after occlusion in the Yorkshire and Ossabaw swine. Diameters were analyzed by multiple diameter measurements. Comparisons of diameters before and after occlusion were made between the right (ipsilateral) and left (contralateral) IIAs.
Statistical analysis
All data in this study are expressed as the mean 6 standard deviation. Differences in data between the groups were compared using Prism 4 (GraphPad Software, La Jolla, Calif) with Student unpaired, two-tailed t-test when only two groups were compared. A P value < .05 was considered statistically significant. Other statistical analyses are noted specifically in the appropriate Results section.
RESULTS
Perioperative events. One Yorkshire pig died during the initial arteriography procedure. In that instance, the procedure was aborted before deployment of the stent and the animal killed because of persistent bradycardia and hypotension. Necroscopy revealed a restrictive pericarditis as the cause of death. This animal was replaced with a subsequent animal for a total of eight Yorkshire pigs that completed the study.
HLI and gait disturbance. The ischemic hindlimb occlusion pressure was significantly depressed in the right vs left leg out to 6 weeks (systolic blood pressure, 31 6 21 vs 83 6 15 mm Hg, respectively; P ¼ .0007). Here, the HLI was depressed throughout the time course of this study, allowing at least a 28-day therapeutic testing window (Fig 2, A and B) . Qualitatively, all animals had grossly normal gait after 2 weeks of ischemia, but a subtle gait disturbance persisted at weeks 4 to 5 after hindlimb ischemia. Here, animals had 6.6 (63.5) abnormal steps of 21 (62) steps during a 10-m walk video.
Ultrasound velocity of common femoral artery. The peak systolic velocity of the common femoral artery was severely depressed throughout the time course of this study (P < .001 at all time points). The greatest increase in velocity occurred between 1 and 2 weeks after occlusion. Velocities in the right hindlimb disappeared and slowly recovered during 5 weeks to 38% of their baseline values. These velocities directly correlated to the gain in HLI values over time. Interestingly, the enddiastolic velocity was not significantly different between groups (Fig 2, C and D) .
Ischemic myopathy. For Yorkshire swine, the muscle myofiber area was decreased in the ischemic compared with the nontreated limbs (P < .05). Representative images of the range in severity of ischemic myopathy are demonstrated in Yorkshire swine compared with human patients in Fig 3. Importantly, the myofiber area was significantly decreased in the ischemic compared with the normal limb (Fig 4) . Similar results were obtained in the fat-fed Ossabaw group with good correlation between manual and MATLAB-generated quantification of ischemic myopathy (Fig 5) .
Time-of-flight flow and WSS analyses. At time of acute occlusion, there was no flow identified in the right common femoral and superficial femoral arteries. At terminal arteriography (5 weeks after ischemia), there was reconstitution of flow to these arteries by branches of the profunda to geniculate arteries (Videos 1 and 2, online only).
Here there was significant delay in filling of the femoral arteries on the right compared with the left side (2.8 seconds vs 0.3 second, respectively; P ¼ .003). In addition, the reversal of flow with retrograde filling of these arteries from the geniculate arteries signifies oscillatory WSS in this artery. Interestingly, at 35 days after ischemia, the left leg (control) continues to demonstrate normal WSS values, but the right (ischemic) limb exhibits very low WSS values (Fig 6) .
Arteriogenesis. There was robust arteriogenesis of the ipsilateral Yorkshire IIA. There was a >50% increase in the diameter of the IIA in the postintervention angiograms compared with the preintervention images. Interestingly, this was not present in the fat-fed Ossabaw swine (Fig 7) .
DISCUSSION
The need to develop animal models of PAD/CLI that reflect the human condition has been recognized for many years. These models could be used to answer questions about whether autologous or allogeneic cells are optimal for certain regenerative therapies, 18 ,24 the type of cells used, [25] [26] [27] the optimal dosing strategies and delivery methods, 28 and the benefits and limitations of cellular expansion vs immediate delivery of cellular therapies. In this study, we introduced and characterized a novel porcine model of ischemic myopathy that has sustained severe ischemia using endovascular occlusion of the EIA and exclusion of its collateral vessels by means of a covered sent graft and vascular plug. This model improves on existing animal models 20 with regard to the degree and duration of ischemia, and it obviates the tissue damage associated with open arterial ligation. [30] [31] [32] In addition, modular ischemia (suprainguinal or infrainguinal) can be added to this model and induced downstream as described in the literature. 33, 34 Arterial occlusions in the suprainguinal and infrainguinal region behave differently, and endovascular therapies in animal models have not been well examined. The only existing studies in the literature were an acute study that looked at distal arterial embolization 35 and a laser occlusion of the iliac artery. The latter had substantial perioperative mortalities, and the report focused on the arterial injury, not the impact of distal ischemia. 36 In contrast, the model described here shares many similarities with the ischemic myopathy seen in PAD patients. 5, 37, 38 Still, there are existing animal models of ischemic myopathy that are already established, 33, 39 and the strengths and limitations of current models have been recently reviewed. 20, 40 These models have been particularly effective for the study of collateral production, but they do not produce the degree or duration of ischemia (mostly recovered within 2 weeks after ischemia) required for testing novel pharmacologic or regenerative therapies. [30] [31] [32] [33] 41 Thus, the useful features of this model for PAD translational research are (1) endovascular delivery of ischemia to avoid local tissue injury, (2) sustained limb ischemia with skeletal myopathy in calf muscles that can be quantified using semiautomated methodology, (3) altered WSS that may be useful in understanding how fluid mechanics inform arterial remodeling in large animals, and (4) demonstration of both robust arteriogenic remodeling in the ipsilateral IIA of Yorkshire swine and diminished response in the fat-fed Ossabaw swine that mimic metabolic syndrome. This difference in arteriogenic potential between the Yorkshire and Ossabaw is similar to that identified clinically in patients with metabolic syndrome. 42 Thus, this model can be tuned to animals like the fat-fed Ossabaw swine to add features like metabolic syndrome, which may affect the specifics of dosing strategies, the choice of pharmaceuticals tested, or the delivery strategy and choice of cells for regenerative therapies. PAD patients have significant ischemic myopathy, 5, 37 and this model demonstrates ischemic changes similar to those seen in patients. 43 Thus, this model is well equipped to test agents designed to improve muscle perfusion and function. Also, the WSS values are similar to those seen in patients on the unaffected (left) side and low WSS values that are consistent with significant arterial disease in the common femoral artery on the affected (right) side. Therefore, pathologic arterial remodeling that occurs in areas of low and oscillatory WSS can be tested in these arteries. This model does have some specific limitations. First, the onset of ischemia is not the typical progressive atherosclerotic occlusion of PAD. The initial ischemic injury is acute with hallmarks of acute limb ischemia. However, after 2 weeks, these animals have recovered the ability to ambulate, the systolic blood pressure ratios are consistent with those seen clinically in PAD, and the ischemic injury to the muscle at termination is consistent with that seen in PAD patients. Still, it is unclear how much the HLI will recover over time. It is possible that animals will behave like patients with inflow disease and plateau at a resting ankle-brachial index of w0.8. Regardless, it remains to be seen how long significant ischemia persists in our model, and it may be desirable to have a prolonged ischemic period for testing some therapeutic agents. Obviously, exercising these animals may bring on a precipitous drop in these ankle-brachial index measurements. Furthermore, given the modular nature of endovascular approaches, a longer therapeutic window could be built into this model by delayed occlusion of the ipsilateral IIA. This would mandate that the right limb be perfused by cross-pelvic collateralization. Also, testing of this model was restricted to female swine. PAD is a significant medical condition for women, 44, 45 and the female sex is frequently understudied in the translational testing of therapeutics. This model may also have utility in therapeutic testing of pharmaceuticals that are not involved in regenerative medicine. Here, this model has been tested in fat-fed Ossabaw to test nitrite delivery on angiogenesis and coronary vasoreactivity in these animals. 21, 22 Finally, the quantification of gait disturbance in this model was underdeveloped and can be better analyzed with existing technology. 46 
CONCLUSIONS
This large animal translational model of ischemic myopathy may be useful to the testing of regenerative therapy. This model can be applied across different types of swine, which can be chosen according to the clinical condition investigators are interested in translating. Future work in applying this model to the testing of novel therapeutics may be useful in identifying the optimal dosages and delivery of these agents.
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